44% recurrence compared to a 53% when treated with a second angioplasty procedure (RR ¼ 0.4, 95% CI ¼ 0.46-1.5, p¼0.48). Thirteen veins developed in-stent restenosis. Five of these veins were treated with a stent-in-stent, this was successful in four of these veins (80%). In the eight vessels where angioplasty was used for in-stent stenosis, 4 vessels developed recurrence (50%). Complications were similar; 1 patient treated with a stent had impingement of the adjacent vein requiring a second stent. In the angioplasty group 1 patient developed transient ST elevations and hypotension and 1 patient experienced PV perforation requiring intubation.
CONCLUSIONS The use of large stents can significantly reduce the risk of restenosis and are more effective than simple balloon angioplasty. However restenosis remains common and warrants on going surveillance after the initial procedures. This may suggest a role for novel approaches including the use of drug coated balloons. METHODS A literature search was performed in MEDLINE, Embase, PubMed, Google Search, and Cochrane databases. Only studies directly comparing SC and TCC of ASDs were included. Of note, by definition and as a limitation of this work, this study compares only device-closeable ASD's (TCC) to all surgically closed ASD's. Outcomes studied were major and minor acute complications, all-cause mortality, residual shunt, reinterventions, ICU admission, and length of stay (LOS). Odds ratios (OR), standardized mean difference (SMD) and 95% confidence intervals (CI) were calculated using the MantelHaenszel method. A random-effect model was used to obtain summary effect. Sensitivity and cumulative analysis was performed for each outcome. All ages were included.
RESULTS 1287 manuscripts were screened. Twenty studies fulfilled the inclusion criteria: all observational studies (total n ¼ 4,673 patients). TCC was superior to SC for the following outcomes: total complications (OR 0.33, 95% CI 0.20 to 0.75; p <0.01), major complications (OR 0.42, 95% CI 0.25 to 0.71; p <0.01), minor complications (OR 0.31, 95% CI 0.16 to 0.57; p <0.01), ICU admission (OR 0.01, 95% CI 0.01 to 0.29; p ¼0.01), and LOS (SMD -2.33, 95% CI -2.81 to -1.85; p <0.01). Residual shunts were more common with TCC (OR 3.28, 95% CI 1.57 to 6.87; p <0.01). No difference was observed for all-cause mortality (OR 0.34, 95% CI 0.08 to 1.49; p ¼0.15) or the need of reintervention (OR 1.39, 95% CI 0.49 to 3.96; p ¼0.61). Amongst adult patients (>18 years) a TCC was associated with shorter LOS (SMD -2.13, 95% CI -2.39 to -1.88; p <0.01).
CONCLUSIONS We present the largest meta-analysis comparing TCC and SC for closure of secundum ASD. Though both approaches are efficacious, for TCC-appropriate ASD's, TCC is associated with shorter LOS, less morbidity and fewer ICU admissions, while SC has a lower rate of residual shunting. Of note, many surgical cases included in this meta-analysis likely could only be closed surgically suggesting that both approaches are of value in the care of patients with ASD. METHODS Consecutive patients undergoing percutaneous ASD closure guided by ICE were enrolled. Defect sizing was conducted with color-Doppler at "stop-flow" during balloon deployment. ICE loops were recorded and retrospectively studied. The length of the compartments of the closure device was measured at horizontal plane. Subsequently, in order to evaluate device deformation, the ratio of the measured to the nominal dimensions of the device was produced. Namely, R-waist (R-W), R-left-atrial-disk (R-LA) and Rright-atrial-disk (R-RA) were calculated.
RESULTS A total of 25 patients were included in the study. In all cases ASD was conducted uneventfully. R-W was 0.65 AE 0.13, R-LA was 0.85 AE 0.09 and R-RA was 0.84 AE 0.07. R-W differed significantly compared to the observed deformation of both disks (R-LA and R-RA), p<0.001. However, R-W was neither correlated with R-LA (r¼0.175, p¼0.404) nor with R-RA (r¼0.123, p¼0.558). This indicates that other factors besides mechanical properties of the device affect disks expansion. 
